Skip to main content
. 2009 Apr 29;330(2):468–475. doi: 10.1124/jpet.108.150011

Fig. 10.

Fig. 10.

Locomotor effects of 10 mg/kg nor-binaltorphimine + 10 mg/kg butorphanol (top), 10 mg/kg nor-binaltorphimine + 10 mg/kg nalbuphine (middle), and 10 mg/kg nor-binaltorphimine + 10 mg/kg nalorphine (bottom) over 5 days of treatment. Left, locomotor activity expressed as distance traveled (centimeters) after saline administration (SAL) and 5 days of drug treatment. Right, locomotor activity on days 1 and 5 expressed as difference from saline control values (centimeters). Significant differences are indicated as follows: a, significantly different from saline (p < 0.05); and b, significantly different from day 1 (p < 0.05). *, nonsignificant difference from day 1 (p = 0.051).